Abenex Continuation Fund Acquires Majority Stake in Europa Group; Europa Acquires APM International

Abenex Invests in Groupe ESCG to Accelerate Expansion

January 6, 2022

Education

French private equity firm Abenex has made a minority growth investment in Groupe ESCG, becoming a reference shareholder to support the school's development alongside founder Gilles Samama. The investment will fund geographic expansion — including planned new campuses in Lyon and Marseille — and operational support to scale ESCG's work-study accounting training programs.

Apax Partners and Fremman Capital acquire co-controlling stakes in Palex Medical

August 1, 2023

Medical Devices

Funds advised by Apax Partners LLP and funds advised by Fremman Capital agreed to acquire co-controlling stakes in Palex Medical, with Fremman remaining an investor while some of its funds and other minority shareholders sell. Palex, a Sant Cugat del Vallès (Barcelona)-headquartered MedTech distributor with ~928 employees, will partner with Apax and Fremman to accelerate pan-European growth and international expansion; the deal is expected to close in Q4 2023 and financial terms were not disclosed.

Abenex Takes Minority Stake in Phenomen

September 6, 2023

Insurance

Abenex, a European private equity firm, has acquired a minority stake in Phenomen, a Paris-based insurtech specializing in contingency, embedded and event cancellation insurance. The investment will support Phenomen's operational and financial strengthening, accelerate its rollout across Europe, and enable transformative M&A to scale its Meetch (embedded insurance) and Leeloo (event cancellation) businesses.

Bain Capital Acquires Apleona from PAI Partners

February 14, 2025

Real Estate

Bain Capital, through a consortium led by its Europe Private Equity team, has agreed to acquire Apleona, the Neu-Isenburg-based European integrated facility management group, from PAI Partners. The deal will support Apleona's continued growth — including European platform expansion, digital transformation and ESG/decarbonisation capabilities — and is subject to customary closing conditions and regulatory approvals.

AmerisourceBergen Acquires PharmaLex from AUCTUS in €1.28bn Transaction

December 31, 2022

Healthcare Services

AmerisourceBergen Corporation acquired a majority stake in PharmaLex from funds advised by AUCTUS Capital Partners AG in a transaction that closed at year-end 2022 for approximately EUR 1.28 billion. PharmaLex, a Germany-headquartered provider of regulatory, clinical development and pharmacovigilance services to the life sciences industry, was grown under AUCTUS through a buy-and-build program of 38 add-ons and will expand AmerisourceBergen's global pharmaceutical solutions.

Abenex Invests in EDL (Edition et Développement Logiciels) to Accelerate Growth

May 11, 2021

Software

Abenex has become a new shareholder in EDL (Edition et Développement Logiciels), the French developer of Xplore, a RIS/PACS and medical-imaging software suite, to support the company’s development, governance structuring and international expansion. The investment will back EDL’s organic growth and targeted acquisitions while facilitating a leadership transition as one founder steps back from operational duties.